Table 3.
Characteristic | Total | ≤40 | >40, ≤60 | >60, ≤80 | >80 | p |
---|---|---|---|---|---|---|
n | 2,492 | 66 | 435 | 1,452 | 539 | |
ARDS | 1,028 (41.3) | 23 (34.8) | 160 (36.8) | 614 (42.3) | 231 (42.9) | 0.116 |
Respiratory failure | 1,779 (71.4) | 39 (59.1) | 288 (66.2) | 1,058 (72.9) | 394 (73.1) | 0.005 |
Acute myocardial infarction | 51(2.0) | 0 (0.0) | 5 (1.1) | 30 (2.1) | 16 (3.0) | 0.144 |
Acute myocardial injury | 381 (15.3) | 5 (7.6) | 44 (10.1) | 232 (16.0) | 100 (18.6) | 0.001 |
Arrhythmia | 130 (5.2) | 5 (7.6) | 11 (2.5) | 81 (5.6) | 33 (6.1) | 0.039 |
Acute kidney injury | 483 (19.4) | 5 (7.6) | 71 (16.3) | 290 (20.0) | 117 (21.7) | 0.014 |
Acute liver injury | 474 (19.0) | 9 (13.6) | 87 (20.0) | 296 (20.4) | 82 (15.2) | 0.039 |
Gastrointestinal bleeding | 49 (2.0) | 3 (4.5) | 10 (2.3) | 28 (1.9) | 8 (1.5) | 0.364 |
Acute ischemic stroke | 38 (1.5) | 0 (0.0) | 5 (1.1) | 17 (1.2) | 16 (3.0) | 0.018 |
Sepsis | 273 (11.0) | 14 (21.2) | 48 (11.0) | 157 (10.8) | 54 (10.0) | 0.054 |
Coagulopathy | 560 (22.5) | 16 (24.2) | 81 (18.6) | 335 (23.1) | 128 (23.7) | 0.201 |
COPD, chronic obstructive pulmonary disease; COVID-19, coronavirus disease 2019; Data are reported as number of patients and percentage in the age group (%).